The TNF-α gene Nco I polymorphism influences the relationship among insulin resistance, percent body fat, and increased serum leptin levels

Diabetes

Volumn 46, Issue 9, 1997, Pages 1468-1472

  Fernandez Real J M ^a   Gutierrez, C ^b   Ricart, W ^a   Casamitjana, R ^c   Fernandez Castaner M ^d   Vendrell, J ^b   Richart, C ^b   Soler, J ^d  

^a HOSPITAL JOSEP TRUETA   (Spain)

^b HOSPITAL UNIVERSITARI JOAN XXIII   (Spain)

^c University Hospital Clinic

^d HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; TUMOR NECROSIS FACTOR ALPHA;

ADIPOCYTE; ADULT; ARTICLE; BODY FAT; CLINICAL ARTICLE; DIABETES MELLITUS; FEMALE; GENE EXPRESSION REGULATION; GENETIC POLYMORPHISM; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; INTRAVENOUS GLUCOSE TOLERANCE TEST; MALE; OBESITY; PRIORITY JOURNAL;

EID: 0030863239     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diab.46.9.1468     Document Type: Article

References (33)

1. Hotamisligil GS, Spiegelman BM: Tumor necrosis factor α: a key component of the obesity-diabetes link. Diabetes 43:1271-1278, 1994
2. Kern PA, Saghizadeh M, Ong JM, Bosch RJ, Deem R, Simsolo RB: The expression of tumor necrosis factor in human adipose tisssue: regulation by obesity, weight loss, and relationship to lipoprotein lipase. J Clin Invest 95:2111-2119, 1995
3. Hotamisligil GS, Arner P, Caro JF, Atkinson RL, Spiegelman BM: Increased adipose tissue expression of tumor necrosis factor-α in human obesity and insulin resistance. J Clin Invest 95:2409-2415, 1995
4. Saghizadeh M, Ong JM, Garvey WT, Henry RR, Kern PA: The expression of TNFα by human muscle: relationship to insulin resistance. J Clin Invest 97:1111-1116, 1996
5. Hotamisligil GS, Shargill NS, Spiegelman BM: Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 259:87-91, 1993
6. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM: Positional cloning of the mouse obese gene and its human homologue. Nature 372:425-432, 1994
7. Maffei M, Halaas J, Ravussin E, Pratley RE, Lee GH, Zhang Y, Fei H, Kim S, Lallone R, Ranganathan S, Kern PA, Friedman JM: Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nature Med 1:1155-1161, 1995
8. Considine RV, Sinha MK, Heiman ML, Kriauciunas A, Stephens TW, Nyce MR, Ohannesian JP, Marco CC, McKee LJ, Bauer TL, Caro JF: Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med 334:292-295, 1996
9. Segal KR, Landt M, Klein S: Relationship between insulin sensitivity and plasma leptin concentration in lean and obese men. Diabetes 45:988-991, 1996
10. Cohen B, Novick D, Rubinstein M: Modulation of insulin activities by leptin. Science 274:1185-1188, 1996
11. Fong CL, Siddiqui AH, Mark DF: Identification and characterization of a novel repressor site in the human tumor necrosis factor alpha gene. Nucleic Acids Res 22:1108-1114, 1994
12. Wilson AG, di Giovine FS, Blakemore AI, Duff GW: Single base polymorphism in the human tumor necrosis factor alpha (TNF alpha) gene detectable by Ncol restriction of PCR product. Hum Mol Gen 1:353, 1992
13. Wilson AG, Symons JA, McDowell TL, di Giovine FS, Duff GW: Effects of a tumour necrosis factor (TNFα) promoter base transition on transcriptional activity. Br J Rheumatol 33 (Suppl. 1):89, 1994
14. Grunfeld C, Zhao C, Fuller J, Pollock A, Moser A, Friedman J, Feingold KR: Endotoxin and cytokines induce expression of leptin, the ob gene product, in hamsters: a role for leptin in the anorexia of infection. J Clin Invest 97:2152-2157, 1996
15. Kirchgessner TG, Choi S: Hormonal and cytokine regulation of leptin production in adipocytes. Diabetes 45 (Suppl. 2):223A, 1996
16. Norman RA, Bogardus C, Ravussin E: Linkage between obesity and a marker near the tumor necrosis factor-α locus in Pima Indians. J Clin Invest 96:158-162, 1995
17. Jeliffe DB: The Assessment of Nutritional Status of the Community. Geneva, World Health Organization, 1966 (WHO monogr. no. 53)
18. Ricart W, Gonzalez-Huix F, Conde V, Grup per l'Evaluació de la Composició Corporal de la Població de Catalunya: The evaluation of the state of nutrition through the determination of anthropometric parameters: new tables in the working population in Catalonia (Spain). Med Clin (Barc) 100:681-691, 1993
19. National Diabetes Data Group: Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 28:1039-1057, 1979
20. Siedel J, Hagele EO, Ziegenhorn J, Wahlefeld AW: Reagent for the enzymatic determination of serum total cholesterol with improved lipolytic efficiency. Clin Chem 29:1075-1080, 1983
21. Kostner GM, Molinari E, Pichler P: Evaluation of a new HDL2/HDL3 quantitation method based on precipitation with polyethylene glycol. Clin Chim Acta 148:139-147, 1985
22. Wahlefeld AW: In Methoden der enzymatischen Analyse. 3rd ed. Vol II. Bergmeyer HU, Ed. Weinheim, Germany, Verlag Chemie, 1974, p. 187
23. Bergman RN, Prager R, Volund A, Olefsky JM: Equivalence of the insulin sensitivity index in man derived by the minimal model method and euglycaemic glucose clamp. J Clin Invest 79:790-800, 1987
24. Rice T, Borecki IB, Bouchard C, Rao DC: Segregation analysis of fat mass and other body composition measures derived from underwater weighing. Am J Hum Genet 52:967-973, 1993
25. Sociedad Española para el Estudio de la Obesidad (SEEDO): Consenso español 1995 para la evaluación de la obesidad y para la realización de estudios epidemiológicos. Med Clin 107:782-787, 1996
26. Hotamisligil GS, Peraldi P, Budavari A, Ellis R, White MF, Spiegelman BM: IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance. Science 271:665-668, 1996
27. Eckel RH: Insulin resistance: an adaptation for weight maintenance. Lancet 340:1452-1453, 1992
28. Cryer A: Comparative biochemistry and physiology of lipoprotein lipase. In Lipoprotein Lipase. Borensztajn J, Ed. Chicago, Evener, 1987, p. 277-327
29. Hamann A, Mantzoros C, Vidal-Puig A, Flier JS: Genetic variability in the TNF-alpha promoter is not associated with type II diabetes mellitus (NIDDM). Biochem Biophys Res Commun 211:833-839, 1995
30. Ofei F, Hurel S, Newkirk J, Sopwith M, Taylor R: Effect of an engineered human anti-TNF-α antibody (CDP571) on insulin sensitivity and glycemic control in patients with NIDDM. Diabetes 45:881-885, 1996
31. Hotamisligil GS, Amer P, Atkinson RL, Spiegelman BM: Differential regulation of the p80 tumor necrosis factor receptor in human obesity and insulin resistance. Diabetes 46:451-455, 1997
32. Leroy P, Dessolin S, Villageois P, Moon BC, Friedman JM, Ailhaud G, Dani C: Expression of ob gene in adipose cells: regulation by insulin. J Biol Chem 271:2365-2368, 1996
33. Cusin I, Sainsbury A, Doyle P, Rohner-Jeanrenaud F, Jeanrenaud B: The ob gene and insulin: a relationship leading to clues to the understanding of obesity. Diabetes 44:1467-1470, 1995